Kalevi Pyörälà

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Anders Olsson, John J.V. McMurray, G Thorgeirsson et al. · The Lancet · 1994 · 8.5K citations

Medicine, Cardiology, Pharmacotherapy +13

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

Steven M. Haffner, Seppo Lehto, Tapani Rönnemaa et al. · New England Journal of Medicine · 1998 · 7.1K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

L Rydén, Eberhard Standl, M. Bartnik et al. · European Heart Journal · 2006 · 1.7K citations · Full text

Medicine, Cardiology, Endocrinology +17

Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

Ian Graham, Dan Atar, Knut Borch‐Johnsen et al. · European Journal of Cardiovascular Prevention & Rehabilitation · 2007 · 1.7K citations

Medicine, Cardiology, Internal Medicine +12

Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Kalevi Pyörälà, Terje R. Pedersen, John Kjekshus et al. · Diabetes Care · 1997 · 1.6K citations

Medicine, Cardiology, Pharmacotherapy +17